What are the latest treatment options for pancreatic cancer

According to the NCCN (National Comprehensive Cancer Network) 2023 Guidelines for Pancreatic Cancer, treatment options are typically determined by the stage of cancer and whether the tumor is resectable (can be surgically removed), borderline resectable, or unresectable. Here are the main treatment approaches:

For Resectable Pancreatic Cancer:

• Surgery (Whipple procedure or distal pancreatectomy) followed by adjuvant chemotherapy
• The NCCN recommends modified FOLFIRINOX or gemcitabine plus capecitabine as preferred adjuvant therapy options

For Borderline Resectable Disease: The American Society of Clinical Oncology (ASCO) guidelines recommend:

• Neoadjuvant therapy (treatment before surgery) with chemotherapy and/or radiation
• Following successful treatment, surgery may become possible
• Followed by additional chemotherapy after surgery

For Unresectable/Metastatic Disease: According to the National Cancer Institute (NCI), standard options include:

• Chemotherapy combinations such as: • FOLFIRINOX (for patients with good performance status) • Gemcitabine plus nab-paclitaxel
• Targeted therapy for specific genetic mutations (like BRCA mutations)
• Clinical trials (which may provide access to newer treatments)

Important notes:

1. Treatment decisions should always be made in consultation with your healthcare team, as they can take into account your specific situation, overall health, and cancer characteristics.

2. The American Cancer Society emphasizes that supportive care (managing symptoms and side effects) should be integrated throughout treatment.

3. Clinical trials may provide access to promising new treatments - discuss with your doctor if you might be eligible for any current trials.

Would you like me to elaborate on any of these treatment options or explain more about a specific approach?